NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 21.23% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 14.90% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 5.62% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.16% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.67% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.61% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.42% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 3.07% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.85% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.75% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.39% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.37% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.35% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.21% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 1.99% |